Chief Executive Robert Ford said the company's "No. 1 priority is getting infants and families the high-quality formulas they need." Abbott Labs Enters Into Consent Decree With FDA at 4:40 p.m. ET incorrectly said the priority was No. 2.

(END) Dow Jones Newswires

May 16, 2022 17:45 ET (21:45 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Abbott Laboratories
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Abbott Laboratories